A detailed history of Nilsine Partners, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Nilsine Partners, LLC holds 5,362 shares of BSX stock, worth $451,158. This represents 0.06% of its overall portfolio holdings.

Number of Shares
5,362
Previous 5,503 2.56%
Holding current value
$451,158
Previous $377 Million 9.56%
% of portfolio
0.06%
Previous 0.05%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$67.33 - $77.71 $9,493 - $10,957
-141 Reduced 2.56%
5,362 $413 Million
Q1 2024

Apr 22, 2024

SELL
$57.6 - $68.62 $4,896 - $5,832
-85 Reduced 1.52%
5,503 $377 Million
Q4 2023

Jan 24, 2024

SELL
$48.64 - $57.81 $194,705 - $231,413
-4,003 Reduced 41.74%
5,588 $323 Million
Q3 2023

Nov 01, 2023

BUY
$50.19 - $54.68 $2,358 - $2,569
47 Added 0.49%
9,591 $506 Million
Q2 2023

Jul 21, 2023

SELL
$49.72 - $54.64 $33,312 - $36,608
-670 Reduced 6.56%
9,544 $516 Million
Q1 2023

May 10, 2023

BUY
$45.09 - $50.03 $460,549 - $511,006
10,214 New
10,214 $511 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $120B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Nilsine Partners, LLC Portfolio

Follow Nilsine Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nilsine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nilsine Partners, LLC with notifications on news.